Find the products and resources you are looking for!
Get in touch!
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Cookie Settings
We use cookies in order to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement.
Thursday, July 5 – Friday, July 6, 2018
Centre de Recherche des Cordeliers (CRC)
Campus des Cordeliers – Amphithéâtre Farabeuf
15 rue de l’école de médecine, 75006 Paris
Thursday, July 5 | |
08:30 a.m. | Opening
Daniel Louvard, France |
08:45 a.m. | Heterogeneity of immune cells and cancer antigens in cancer vaccines and immunotherapy: mouse models and translation to human clinical trials (EATI Honorary Lecture 2018)
Jay A. Berzofsky, USA |
09:30 a.m. | Host-Microbiome interactions – reality or myth? Harry Sokol, France |
10:00 a.m. | Programming tissue residency to enhance immunity to infection and tumors Ananda W. Goldrath, USA |
10:30 a.m. | Coffee break |
11:00 a.m. | Immunotherapy of cancer: clinical experimentation Fabrice André, France |
11:30 a.m. | From initiation to treatment: microbial influences in carcinogenesis Christian Jobin, USA |
12:00 p.m. | Lunch break |
02:00 p.m. | Defining molecular identity of intratumoral T cells to design better cancer immunotherapies Sergio Abrignani, Italy |
02:30 p.m. | Molecular and epigenetic programs defining tumor-specific T cell dysfunction Andrea Schietenger, USA |
03:00 p.m. | Immune parameters for predicting patient outcome Christian Ottensmeier, UK |
03:30 p.m. | Coffee break |
04:00 p.m. | IL-18 drives immunosuppression in multiple myeloma Ludovic Martinet, France |
04:30 p.m. | Induction and transcriptional regulation of the “co-inhibitory” gene module in T cells Vijay Kuchroo, USA |
5:00 p.m. | Celebration party “20th Year Miltenyi Biotec France” |
Friday, July 6 | |
09:15 a.m. | Welcome Laurence Zitvogel / Guido Kroemer / Hervé Fridman, France |
09:30 a.m. | The role of GM-CSF in graft-vs-host disease: uncoupling of GvHD and GvL immunity Burkhardt Becher, Switzerland |
10:00 a.m. | Myeloid cells contribution to tumor outcome Miriam Merad, USA |
10:30 a.m. | Coffee break |
11:00 a.m. | Genetic screens to identify immunotherapy targets Nicholas Haining, USA |
11:30 a.m. | Cancer evolution and immune escape: TRACERx Rachel Rosenthal, UK |
12:00 p.m. | Lunch break |
02:00 p.m. | Dynamics of epigenetic traits in triple-negative breast cancer Céline Vallot, France |
02:30 p.m. | Single-cell transcriptomic network inference as a new approach to better characterize autoinflammatory diseases Mickaël Ménager, France |
03:00 p.m. | Molecular basis of T cell exhaustion: insights for immunotherapy E. John Wherry, USA |
03:30 p.m. | Coffee break |
04:00 p.m. | Metabolic interventions for the immunoprophylaxis of breast cancer Guido Kroemer, France |
04:30 p.m. | Closing / Farewell Jean Magon, France |
For any questions, please send an e-mail to macs@miltenyibiotec.fr or call +33 1 56 98 16 16.
Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.